Parkinson's disease (PD) is a progressive neurodegenerative disorder that poses significant challenges to healthcare professionals. As the disease continues to affect millions globally, understanding its pathology, diagnosis, and treatment is paramount.
PD primarily affects the substantia nigra, a region of the brain responsible for reward and movement. Degeneration of dopamine-producing neurons results in motor symptoms such as bradykinesia, rigidity, and tremor. Non-motor symptoms, including depression and cognitive impairment, are also common due to the involvement of other neurotransmitter systems.
Diagnosis is primarily clinical, based on the presence of cardinal motor symptoms and their response to dopaminergic therapy. Neuroimaging techniques like DAT-SPECT can provide supportive evidence, but are not required for diagnosis. Early detection remains a challenge due to the non-specific nature of early symptoms.
Management of PD involves both pharmacological and non-pharmacological strategies. Levodopa remains the most effective medication for motor symptoms, but its long-term use can lead to motor complications. Non-pharmacological interventions, including physiotherapy and occupational therapy, are crucial for maintaining patient’s quality of life.
Current research focuses on developing disease-modifying therapies. Deep brain stimulation and infusion therapies have shown promise in managing motor fluctuations. Moreover, the potential role of gut microbiota in PD pathogenesis has opened new avenues for therapeutic intervention.
Comprehending the complexities of Parkinson's disease is essential for healthcare professionals to provide optimal care. Continued research and advancements in the understanding of its pathogenesis, diagnosis, and treatment will hopefully lead to more effective strategies for managing this debilitating condition.
1.
The need for more Latinx participants in Alzheimer's trials is urgent.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
5.
Study offers clearer picture of childhood brain tumor survival
1.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Comprehensive Standards in Oncology for Modern Medicine
4.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
5.
Practical Standards in Hematology for Healthcare Excellence
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation